Correlation Between ResMed and Daxor
Can any of the company-specific risk be diversified away by investing in both ResMed and Daxor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ResMed and Daxor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ResMed Inc and Daxor, you can compare the effects of market volatilities on ResMed and Daxor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ResMed with a short position of Daxor. Check out your portfolio center. Please also check ongoing floating volatility patterns of ResMed and Daxor.
Diversification Opportunities for ResMed and Daxor
Very weak diversification
The 3 months correlation between ResMed and Daxor is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding ResMed Inc and Daxor in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daxor and ResMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ResMed Inc are associated (or correlated) with Daxor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daxor has no effect on the direction of ResMed i.e., ResMed and Daxor go up and down completely randomly.
Pair Corralation between ResMed and Daxor
Considering the 90-day investment horizon ResMed Inc is expected to generate 0.8 times more return on investment than Daxor. However, ResMed Inc is 1.25 times less risky than Daxor. It trades about -0.03 of its potential returns per unit of risk. Daxor is currently generating about -0.14 per unit of risk. If you would invest 24,437 in ResMed Inc on December 2, 2024 and sell it today you would lose (1,085) from holding ResMed Inc or give up 4.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
ResMed Inc vs. Daxor
Performance |
Timeline |
ResMed Inc |
Daxor |
ResMed and Daxor Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ResMed and Daxor
The main advantage of trading using opposite ResMed and Daxor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ResMed position performs unexpectedly, Daxor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daxor will offset losses from the drop in Daxor's long position.ResMed vs. Teleflex Incorporated | ResMed vs. West Pharmaceutical Services | ResMed vs. Alcon AG | ResMed vs. ICU Medical |
Daxor vs. InfuSystems Holdings | Daxor vs. Meihua International Medical | Daxor vs. Repro Med Systems | Daxor vs. LeMaitre Vascular |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Valuation Check real value of public entities based on technical and fundamental data |